October 7, 2024 by adminparwaz WHO: Long-acting Injectable Lenacapavir Proves Effective in HIV Prevention for Women WHO is pleased with the effectiveness of long-acting lenacapavir as PrEP in preventing HIV acquisition among women. The PURPOSE 1 trial results confirmed the safety and efficacy of this injectable
